This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

£200 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
4 - 6 June, 2024
Excel London Platinum Suite

Leonard Wossnig, Ph.D.
Chief Technology Officer at LabGenius


Leonard Wossnig is CTO at antibody discovery company LabGenius where he leads a team of Data Scientists, Software Engineers, and Automation Experts to enhance LabGenius’ data-driven platform capabilities. In 2018, Leonard co-founded Rahko, a quantum machine learning company merging computational chemistry, ML, and quantum physics to drive a better understanding of drug behaviour. Leonard led Rahko from inception through to its acquisition by Odyssey Therapeutics in 2021, where Leonard became the VP of AI before joining LabGenius. Leonard holds a Google PhD in Computer Science from UCL where he is now an Honorary Research Fellow.

Agenda Sessions

  • Iterative Active Learning for the Rapid Discovery of Best-in-class Multispecific Antibody Therapeutics